Genprex (GNPX) Operating Income (2016 - 2025)

Genprex (GNPX) has 9 years of Operating Income data on record, last reported at -$3.3 million in Q3 2025.

  • For Q3 2025, Operating Income rose 22.61% year-over-year to -$3.3 million; the TTM value through Sep 2025 reached -$16.3 million, up 28.39%, while the annual FY2024 figure was -$21.2 million, 31.82% up from the prior year.
  • Operating Income reached -$3.3 million in Q3 2025 per GNPX's latest filing, up from -$4.7 million in the prior quarter.
  • Across five years, Operating Income topped out at -$3.3 million in Q3 2025 and bottomed at -$9.3 million in Q1 2023.
  • Average Operating Income over 5 years is -$5.7 million, with a median of -$5.8 million recorded in 2022.
  • Peak YoY movement for Operating Income: plummeted 79.43% in 2022, then surged 44.47% in 2024.
  • A 5-year view of Operating Income shows it stood at -$6.8 million in 2021, then increased by 2.56% to -$6.6 million in 2022, then increased by 9.29% to -$6.0 million in 2023, then grew by 27.35% to -$4.3 million in 2024, then increased by 22.83% to -$3.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Income were -$3.3 million in Q3 2025, -$4.7 million in Q2 2025, and -$4.0 million in Q1 2025.